why choose us

First received: July 12, 2023

Clinical Trial: Outpatient Administration of Teclistamab for Multiple Myeloma

Study Status: Completed

Recruit Status: RECRUITING

Condition: Multiple Myeloma

Study Type: INTERVENTIONAL


Official Title: A Study of Outpatient Administration of Teclistamab, a BCMA-targeting Bispecific Antibody, in Multiple Myeloma Patients

Brief Summary: This is a phase II study to evaluate the Outpatient Administration of Teclistamab in Multiple Myeloma Patients

Read more